URGN - UroGen Pharma Ltd
UroGen Pharma Ltd Logo

URGN - UroGen Pharma Ltd

https://www.urogen.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

None

52W High
$21.02
52W Low
$3.42
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
1.12
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-2.63
EV/Revenue (<3 favorable)
8.74
P/S (TTM) (<3 favorable)
9.27
P/B (<3 favorable)
19.27
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
6.86%
Institutions (25–75% balanced)
98.52%
Shares Outstanding
46,264,100
Float
37,033,500
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
94,238,000
Gross Profit (TTM)
83,434,000
EPS (TTM)
-3.01
Profit Margin (>10% good)
-1.64%
Operating Margin (TTM) (higher better)
-1.71%
ROE (TTM) (>15% strong)
-14.81%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.11
Momentum
Bearish momentum
Value
0.3707
Previous
0.4940
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025